Silencing a brain receptor curbs cancer cachexia and boosts mouse survival

MedicalXpress | 八月 02, 2026

A new path has opened toward stopping cancer-associated cachexia, a devastating complication that gradually wastes patients away. A KAIST research team has developed an RNA-based therapeutic strategy that blocks a brain signal to prevent muscle loss and extend survival.